George H. Caughey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
George H. Caughey has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Paul J Wolters
2 shared publicationsWilfred W Raymond
2 shared publicationsC. Malmsten
Cardiovascular Research Institute and Department of Medicine, University of California at San Francisco, San Francisco, California, USA
1 shared publication- Christian P. Sommerhoff
Abteilung Klinische Chemie und Klinische Biochemie, Chirurgischen Klinik Innenstadt, Klinikum der Ludwig-Maximilians-Universität, Munich, Germany
1 shared publication D. J. Muilenburg
Cardiovascular Research Institute and Department of Medicine, University of California at San Francisco, San Francisco, California, USA
1 shared publicationD. Soto
Cardiovascular Research Institute and Department of Medicine, University of California at San Francisco, San Francisco, California 94143-0911, USA
1 shared publication
Latest Publications
- 1 August 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (8) , 1055-1066
Transcript Signatures of Lymphocytic Bronchitis in Lung Allograft Biopsy Specimens
- 1 August 2005
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 24 (8) , 1055-1066
Transcript Signatures of Lymphocytic Bronchitis in Lung Allograft Biopsy Specimens
- 1 December 2004
- Published by Wiley in Clinical & Experimental Allergy Reviews
- Vol. 4 (s2) , 96-101
Genetic insights into mast cell chymase and tryptase function
Summary: As the major secreted proteins of degranulating mast cells, chymases and tryptases have long been suspected to be perpetrators of pathology in asthma and other forms of allergic disease. Indeed, the preponderance of evidence now suggests that these enzymes, collectively, are guilty. However, confusion remains over which are most culpable and which of them produce what kinds of pathology. This confusion has several causes, including daunting, nonsystematic nomenclatures, unexplained multiplicities of closely related genes in animal models of allergic disease, uncertainty over which genes deserve to be labelled ‘pseudo’, perplexing allelic relationships and, until recently, a shortage of data correlating enzyme structure with function. Fortunately, recent developments bring these elements into sharper focus. This brief review summarizes some of these developments and discusses how they help to identify the enzymes likely to be important in allergic disease.
- 1 December 2004
- Published by Wiley in Clinical & Experimental Allergy Reviews
- Vol. 4 (s2) , 96-101
Genetic insights into mast cell chymase and tryptase function
Summary: As the major secreted proteins of degranulating mast cells, chymases and tryptases have long been suspected to be perpetrators of pathology in asthma and other forms of allergic disease. Indeed, the preponderance of evidence now suggests that these enzymes, collectively, are guilty. However, confusion remains over which are most culpable and which of them produce what kinds of pathology. This confusion has several causes, including daunting, nonsystematic nomenclatures, unexplained multiplicities of closely related genes in animal models of allergic disease, uncertainty over which genes deserve to be labelled ‘pseudo’, perplexing allelic relationships and, until recently, a shortage of data correlating enzyme structure with function. Fortunately, recent developments bring these elements into sharper focus. This brief review summarizes some of these developments and discusses how they help to identify the enzymes likely to be important in allergic disease.
- 1 February 2003
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 28 (2) , 129-132
Building A Better Heparin
- 1 February 2003
- Published by Oxford University Press (OUP) in American Journal of Respiratory Cell and Molecular Biology
- Vol. 28 (2) , 129-132
Building A Better Heparin
- 1 September 2002
- Published by Elsevier in Molecular Immunology
- Vol. 38 (16-18) , 1353-1357
New developments in the genetics and activation of mast cell proteases
- 1 September 2002
- Published by Elsevier in Molecular Immunology
- Vol. 38 (16-18) , 1353-1357
New developments in the genetics and activation of mast cell proteases
- 5 July 2002
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 32 (7) , 1000-1006
Genetic deficiency of human mast cell a‐tryptase
Summary: Background Human α‐ and β‐tryptases are proteases secreted by mast cells. Beta (but not α) tryptases are implicated in asthma. Genes encoding both types of tryptases cluster on chromosome 16p13.3.Objective This study examines the hypothesis, generated from mapping data, that α‐alleles compete with some β‐alleles at one locus and that an adjacent locus contains β‐alleles exclusively. This hypothesis predicts that β‐alleles outnumber α and that some genomes lack α genes altogether.Methods To test this hypothesis, we developed PCR‐based techniques to distinguish α from β genes. We then genotyped genomic DNA from individuals and tryptase‐expressing cell lines.Results In support of our hypothesis, we find that α‐tryptase deficiency affects 80/274 (29%) of individuals surveyed. The genotype of the α‐deficient individuals is ββββ, due to inheritance of four β genes. The percentage of the population with the mixed genotypes ααββ and αβββ is 21% and 50%, respectively. Accounting for all α‐ and β‐alleles at the tandem loci on 16p13.3, overall α‐allele frequency is only 0.23, with β‐alleles considerably outnumbering α as hypothesized. In samples of defined ethnicity, α deficiency affects 45% of Caucasians, but a much lower percentage of other backgrounds, including African‐Americans and Asians. Examination of cell lines reveals that HMC‐1 and U‐937 lack α‐genes; thus, lack of α transcripts in these cells is due to absence of α‐genes rather than β‐selective transcription. By contrast, α‐transcribing Mono Mac 6 and KU812 cells contain α‐ and β‐genes.Conclusions Genetic α‐tryptase deficiency is common and varies strikingly between ethnic groups. Because β‐tryptases are implicated in allergic disorders, inherited differences in α/β‐genotype may affect disease susceptibility, severity and response to tryptase inhibitor therapy.
- 5 July 2002
- Published by Wiley in Clinical & Experimental Allergy
- Vol. 32 (7) , 1000-1006
Genetic deficiency of human mast cell a‐tryptase
Summary: Background Human α‐ and β‐tryptases are proteases secreted by mast cells. Beta (but not α) tryptases are implicated in asthma. Genes encoding both types of tryptases cluster on chromosome 16p13.3.Objective This study examines the hypothesis, generated from mapping data, that α‐alleles compete with some β‐alleles at one locus and that an adjacent locus contains β‐alleles exclusively. This hypothesis predicts that β‐alleles outnumber α and that some genomes lack α genes altogether.Methods To test this hypothesis, we developed PCR‐based techniques to distinguish α from β genes. We then genotyped genomic DNA from individuals and tryptase‐expressing cell lines.Results In support of our hypothesis, we find that α‐tryptase deficiency affects 80/274 (29%) of individuals surveyed. The genotype of the α‐deficient individuals is ββββ, due to inheritance of four β genes. The percentage of the population with the mixed genotypes ααββ and αβββ is 21% and 50%, respectively. Accounting for all α‐ and β‐alleles at the tandem loci on 16p13.3, overall α‐allele frequency is only 0.23, with β‐alleles considerably outnumbering α as hypothesized. In samples of defined ethnicity, α deficiency affects 45% of Caucasians, but a much lower percentage of other backgrounds, including African‐Americans and Asians. Examination of cell lines reveals that HMC‐1 and U‐937 lack α‐genes; thus, lack of α transcripts in these cells is due to absence of α‐genes rather than β‐selective transcription. By contrast, α‐transcribing Mono Mac 6 and KU812 cells contain α‐ and β‐genes.Conclusions Genetic α‐tryptase deficiency is common and varies strikingly between ethnic groups. Because β‐tryptases are implicated in allergic disorders, inherited differences in α/β‐genotype may affect disease susceptibility, severity and response to tryptase inhibitor therapy.
- 1 July 2000
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
- Vol. 1480 (1-2) , 245-257
Angiotensin II generation by mast cell α- and β-chymases
- 1 July 2000
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
- Vol. 1480 (1-2) , 245-257
Angiotensin II generation by mast cell α- and β-chymases
- 15 June 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (12) , 6566-6575
Characterization of Human γ-Tryptases, Novel Members of the Chromosome 16p Mast Cell Tryptase and Prostasin Gene Families
Previously, this laboratory identified clusters of α-, β-, and mast cell protease-7-like tryptase genes on human chromosome 16p13.3. The present work characterizes adjacent genes encoding novel serine proteases, termed γ-tryptases, and generates a refined map of the multitryptase locus. Each γ gene lies between an α1H Ca2+ channel gene (CACNA1H) and a βII- or βIII-tryptase gene and is ∼30 kb from polymorphic minisatellite MS205. The tryptase locus also contains at least four tryptase-like pseudogenes, including mastin, a gene expressed in dogs but not in humans. Genomic DNA blotting results suggest that γI- and γII-tryptases are alleles at the same site. βII- and βIII-tryptases appear to be alleles at a neighboring site, and αII- and βI-tryptases appear to be alleles at a third site. γ-Tryptases are transcribed in lung, intestine, and in several other tissues and in a mast cell line (HMC-1) that also expresses γ-tryptase protein. Immunohistochemical analysis suggests that γ-tryptase is expressed by airway mast cells. γ-Tryptase catalytic domains are ∼48% identical with those of known mast cell tryptases and possess mouse homologues. We predict that γ-tryptases are glycosylated oligomers with tryptic substrate specificity and a distinct mode of activation. A feature not found in described tryptases is a C-terminal hydrophobic domain, which may be a membrane anchor. Although the catalytic domains contain tryptase-like features, the hydrophobic segment and intron-exon organization are more closely related to another recently described protease, prostasin. In summary, this work describes γ-tryptases, which are novel members of chromosome 16p tryptase/prostasin gene families. Their unique features suggest possibly novel functions.
- 15 June 2000
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 164 (12) , 6566-6575
Characterization of Human γ-Tryptases, Novel Members of the Chromosome 16p Mast Cell Tryptase and Prostasin Gene Families
Previously, this laboratory identified clusters of α-, β-, and mast cell protease-7-like tryptase genes on human chromosome 16p13.3. The present work characterizes adjacent genes encoding novel serine proteases, termed γ-tryptases, and generates a refined map of the multitryptase locus. Each γ gene lies between an α1H Ca2+ channel gene (CACNA1H) and a βII- or βIII-tryptase gene and is ∼30 kb from polymorphic minisatellite MS205. The tryptase locus also contains at least four tryptase-like pseudogenes, including mastin, a gene expressed in dogs but not in humans. Genomic DNA blotting results suggest that γI- and γII-tryptases are alleles at the same site. βII- and βIII-tryptases appear to be alleles at a neighboring site, and αII- and βI-tryptases appear to be alleles at a third site. γ-Tryptases are transcribed in lung, intestine, and in several other tissues and in a mast cell line (HMC-1) that also expresses γ-tryptase protein. Immunohistochemical analysis suggests that γ-tryptase is expressed by airway mast cells. γ-Tryptase catalytic domains are ∼48% identical with those of known mast cell tryptases and possess mouse homologues. We predict that γ-tryptases are glycosylated oligomers with tryptic substrate specificity and a distinct mode of activation. A feature not found in described tryptases is a C-terminal hydrophobic domain, which may be a membrane anchor. Although the catalytic domains contain tryptase-like features, the hydrophobic segment and intron-exon organization are more closely related to another recently described protease, prostasin. In summary, this work describes γ-tryptases, which are novel members of chromosome 16p tryptase/prostasin gene families. Their unique features suggest possibly novel functions.
- Open Access
- 1 November 1997
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 159 (9) , 4367-4375
Cloning and expression of the dog mast cell alpha-chymase gene
Chymases are chymotrypsin-like serine proteinases secreted by mast cells. Alpha- and beta-chymases differ in structure, function, and mast cell subset- and species-specific expression. Seeking genetic regulatory elements shared by alpha-chymases, we sequenced the dog alpha-gene. Extensive homology was found in intronic and flanking sequences of the dog, human, and mouse alpha-chymase genes, but little in corresponding beta-chymase sequences. Repetitive elements probably derived from retroposons are unique features of the dog flank. DNA blots suggest that the dog alpha-gene, like its human counterpart, may be the genome’s sole chymase, unlike in rodents, in which beta-chymases predominate. Nuclear runoff studies predict that transcriptional mechanisms explain differences in steady state chymase and tryptase mRNA levels between mastocytoma and non-mast cells. In dog BR mastocytoma cells incubated with phorbol ester, high steady state levels of alpha-chymase mRNA drop dramatically with little change in tryptase mRNA, whereas dexamethasone decreases expression of both mRNAs. Portions of the dog or human gene 5’ flank transfected into BR cells drive expression of a reporter gene and define regions with active promoters. Thus, BR cells express high levels of alpha-chymase mRNA regulated independently of tryptase and support transcription using dog or human promoters. These studies reinforce the alphabeta-chymase dichotomy and suggest the utility of BR cells in probing regulation of alpha-chymase expression.
- 1 November 1997
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 159 (9) , 4367-4375
Open AccessCloning and expression of the dog mast cell alpha-chymase gene
Chymases are chymotrypsin-like serine proteinases secreted by mast cells. Alpha- and beta-chymases differ in structure, function, and mast cell subset- and species-specific expression. Seeking genetic regulatory elements shared by alpha-chymases, we sequenced the dog alpha-gene. Extensive homology was found in intronic and flanking sequences of the dog, human, and mouse alpha-chymase genes, but little in corresponding beta-chymase sequences. Repetitive elements probably derived from retroposons are unique features of the dog flank. DNA blots suggest that the dog alpha-gene, like its human counterpart, may be the genome’s sole chymase, unlike in rodents, in which beta-chymases predominate. Nuclear runoff studies predict that transcriptional mechanisms explain differences in steady state chymase and tryptase mRNA levels between mastocytoma and non-mast cells. In dog BR mastocytoma cells incubated with phorbol ester, high steady state levels of alpha-chymase mRNA drop dramatically with little change in tryptase mRNA, whereas dexamethasone decreases expression of both mRNAs. Portions of the dog or human gene 5’ flank transfected into BR cells drive expression of a reporter gene and define regions with active promoters. Thus, BR cells express high levels of alpha-chymase mRNA regulated independently of tryptase and support transcription using dog or human promoters. These studies reinforce the alphabeta-chymase dichotomy and suggest the utility of BR cells in probing regulation of alpha-chymase expression.
- 1 November 1996
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 271 (5) , L796-L803
Classical second messengers are not involved in proteinase-induced degranulation of airway gland cells
Neutral serine proteinases such as mast cell chymase, cathepsin G, and neutrophil elastase are far more potent secretagogues for airway gland serous cells than all other agonists studied (e.g., histamine and bradykinin). To determine the mechanism of proteinase-induced secretion, we investigated the stimulation-secretion coupling in cultured bovine serous cells. Histamine stimulates degranulation of serous cells via adenosine 3', 5'-cyclic monophosphate-, protein kinase C-, and intracellular Ca2+ concentration ([Ca2+]i)-dependent pathways. Similarly, bradykinin-induced secretion involves inositol phosphates, protein kinase C, and [Ca2+]i. Degranulation caused by both agonists also depends on the activity of an endogenous metalloprotease, which is required in a late step of stimulation-secretion coupling, i.e., after Ca2+ entry. On the basis of the effect of different inhibitors, this metalloprotease is a Zn(2+)- and Ca(2+)-dependent enzyme similar to a gelatinase A synthesized by serous cells. In marked contrast to other secretagogues, degranulation induced by chymase, cathepsin G, and neutrophil elastase neither involves the classical second messengers nor the activity of the endogenous metalloprotease. These observations suggest that exogenous proteinases such as chymase, cathepsin G, and elastase may substitute for or mimic the action of an endogenous metalloprotease and directly activate degranulation, bypassing the signal transduction mechanisms necessary for secretion caused by other agonists.
- 1 November 1996
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 271 (5) , L796-L803
Classical second messengers are not involved in proteinase-induced degranulation of airway gland cells
Neutral serine proteinases such as mast cell chymase, cathepsin G, and neutrophil elastase are far more potent secretagogues for airway gland serous cells than all other agonists studied (e.g., histamine and bradykinin). To determine the mechanism of proteinase-induced secretion, we investigated the stimulation-secretion coupling in cultured bovine serous cells. Histamine stimulates degranulation of serous cells via adenosine 3', 5'-cyclic monophosphate-, protein kinase C-, and intracellular Ca2+ concentration ([Ca2+]i)-dependent pathways. Similarly, bradykinin-induced secretion involves inositol phosphates, protein kinase C, and [Ca2+]i. Degranulation caused by both agonists also depends on the activity of an endogenous metalloprotease, which is required in a late step of stimulation-secretion coupling, i.e., after Ca2+ entry. On the basis of the effect of different inhibitors, this metalloprotease is a Zn(2+)- and Ca(2+)-dependent enzyme similar to a gelatinase A synthesized by serous cells. In marked contrast to other secretagogues, degranulation induced by chymase, cathepsin G, and neutrophil elastase neither involves the classical second messengers nor the activity of the endogenous metalloprotease. These observations suggest that exogenous proteinases such as chymase, cathepsin G, and elastase may substitute for or mimic the action of an endogenous metalloprotease and directly activate degranulation, bypassing the signal transduction mechanisms necessary for secretion caused by other agonists.